The Trump administration Monday put forward a series of guidelines for testing and rapid response programs in anticipation of reopening the nation’s economy.

The effort is meant to be a partnership between federal, state, local and tribal governments and the private sector. The federal government will support state-based efforts by expanding the number of testing platforms, increasing testing and laboratory supplies and capacity, and enhancing sample collection.

As part of the effort, the Centers for Disease Control and Prevention updated its evaluation and laboratory testing criteria, stating that “increasing testing capacity will allow clinicians to consider COVID-19 testing for a wider group of symptomatic patients and persons without symptoms in certain situations.”

The following remain high priorities for COVID-19 testing:

  • hospitalized patients;
  • health care facility workers, workers in congregate living settings and first responders with symptoms;
  • residents in long-term care facilities or other congregate living settings, including prisons and shelters, with symptoms; and
  • individuals identified through public health cluster and selected contact investigations.

A second, priority tier was established for individuals with symptoms for potential COVID-19 infection, along with those who are without symptoms who are prioritized by health departments and clinicians based on state and local plans

Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…